Collegium Pharmaceutical (COLL) Depreciation & Amortization - Total (2025 - 2026)
Collegium Pharmaceutical (COLL) recorded quarterly Depreciation & Amortization - Total of $463000.0 in Q1 2026, down 57.56% quarter-over-quarter from $1.1 million in Q1 2025, and down 57.56% on a YoY basis from $1.1 million in Q1 2025.
Collegium Pharmaceutical (COLL) Depreciation & Amortization - Total (2025 - 2026) Analysis & Trends
Collegium Pharmaceutical's Depreciation & Amortization - Total history runs 2 years deep, the most recent figure standing at $463000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization - Total fell 57.56% year-over-year to $463000.0; the TTM figure through Mar 2026 stood at $463000.0 (down 57.56% YoY), while the FY2025 annual figure was $4.2 million, up 8.45% from the prior year.
- Depreciation & Amortization - Total was $463000.0 for Q1 2026 at Collegium Pharmaceutical, down from $1.1 million in the prior quarter.
- In the past five years, Depreciation & Amortization - Total ranged from a high of $1.1 million in Q1 2025 to a low of $463000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Collegium Pharmaceutical | 1.10 Bn | 813.71 Mn | 117.25 Mn | 463,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 463,000.00 |
| Mar 31, 2025 | 1.09 Mn |